Author

A. G. Robling

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Bioengineering· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 5 Organism:mouse· 5 Approach:experimental assay· 4 Research Focus:differential expression· 3 Assay:proteomics· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

D. Horan· 2 shared A. Bonetto· 1 shared A. L. Mosley· 1 shared A. Millan· 1 shared A. Mohamed· 1 shared A. Narasimhan· 1 shared A. Young· 1 shared B. Chicana· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Horan

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Gemcitabine plus nab-paclitaxel preserves skeletal and cardiac mass and function in a murine model of pancreatic cancer cachexia

A. Narasimhan, D. Jengelley, J. Huot, T. Umberger, E. Doud, A. L. Mosley, M. Wang, X. Zhong, B. Counts, J. Rupert, A. Young, A. Bonetto, D. Horan, A. G. Robling, M. Fishel, , T. Zimmers

This study shows that gemcitabine plus nab-paclitaxel reduces tumor burden and prevents muscle and cardiac wasting in a murine model of pancreatic cancer cachexia.

bioRxiv · Apr 15, 2023 · PreprintCancer Biology

Single Cell Cortical Bone Transcriptomics Defines Novel Osteolineage Gene Sets Altered in Chronic Kidney Disease

R. Agoro, I. Nookaew, M. Noonan, Y. G. Marambio, S. Liu, W. Chang, H. Gao, L. M. Hibbard, C. E. Metzger, D. Horan, W. R. Thompson, X. Xuei, Y. Liu, C. Zhang, A. G. Robling, , K. E. White

The paper defines novel osteolineage gene sets using single-cell transcriptomics and identifies molecular defects in a CKD mouse model.

Frontiers in Endocrinology · Jan 26, 2023Peer-reviewedCell Biology

Suppression of sost/sclerostin and dickkopf-1 promote intervertebral disc structure in mice

T. M. Kroon, P. Niziolek, D. Edwards, E. L. Clinkenbeard, A. G. Robling, N. Holguin

This study shows that suppressing sclerostin or dkk1 promotes intervertebral disc structure by enhancing Wnt signaling, but sclerostin also reduces cellular stress pathways.

bioRxiv · Jul 1, 2021 · PreprintBioengineering

Sclerostin depletion induces inflammation in the bone marrow of mice

C. Donham, B. Chicana, A. G. Robling, A. Mohamed, S. Elizaldi, M. Chi, B. Freeman, A. Millan, D. Murguesh, G. G. Loots, J. O. Manilay

This study shows that sclerostin depletion in mice leads to myeloid-biased hematopoiesis and increased inflammation in the bone marrow.

bioRxiv · Nov 1, 2020Immunology

Osteocytes remodel bone by TGF-β-induced YAP/TAZ signaling

C. D. Kegelman, J. C. Coulombe, K. M. Jordan, D. J. Horan, L. D. Qin, A. G. Robling, V. L. Ferguson, T. M. Bellido, J. D. Boerckel

This study shows YAP/TAZ signaling in osteocytes is downstream of TGF-β and controls bone remodeling by regulating matrix proteases and coordinating osteoblast/osteoclast activity.

bioRxiv · Apr 17, 2019 · PreprintCell Biology